Bernhardt G Zeiher - Net Worth and Insider Trading

Bernhardt G Zeiher Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bernhardt G Zeiher owns 1 companies in total, including Entrada Therapeutics Inc (TRDA) .

Click here to see the complete history of Bernhardt G Zeiher’s form 4 insider trades.

Insider Ownership Summary of Bernhardt G Zeiher

Ticker	Comapny	Transaction Date	Type of Owner
TRDA	Entrada Therapeutics Inc	2023-04-04	director

Bernhardt G Zeiher Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bernhardt G Zeiher Ownership Network

Ownership Network List of Bernhardt G Zeiher

No Data

Ownership Network Relation of Bernhardt G Zeiher

Bernhardt G Zeiher Owned Company Details

What does Entrada Therapeutics Inc do?

Who are the key executives at Entrada Therapeutics Inc?

Bernhardt G Zeiher is the director of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Scientific Officer Natarajan Sethuraman , Chief Operating Officer Nathan J Dowden , and Chief Financial Officer Kory James Wentworth .

Entrada Therapeutics Inc (TRDA) Insider Trades Summary

Over the past 18 months, Bernhardt G Zeiher made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 18,992 shares made by Dipal Doshi , a net sale of 49,989 shares made by Kory James Wentworth , and a net sale of 55,277 shares made by Nathan J Dowden .

In summary, during the past 3 months, insiders sold 40,733 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 40,733 shares. During the past 18 months, 197,159 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 151,791 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entrada Therapeutics Inc Insider Transactions

No Available Data

Bernhardt G Zeiher Mailing Address

Above is the net worth, insider trading, and ownership report for Bernhardt G Zeiher. You might contact Bernhardt G Zeiher via mailing address: Entrada Therapeutics, Inc., 6 Tide Street, Boston Ma 02210.

Discussions on Bernhardt G Zeiher

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.